The CRO concept sector declined in the short term, with nearshore protein falling more than 8%, while Lanwei Medicine, Yiqiao Shenzhou, Lingkang Pharmaceutical, and Jinshi Ya Pharmaceutical followed suit.

The CRO concept sector declined in the short term, with nearshore protein falling more than 8%, while Lanwei Medicine, Yiqiao Shenzhou, Lingkang Pharmaceutical, and Jinshi Ya Pharmaceutical followed suit.